Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nuriye YILDIRIM ÖZDEMİR"'
Autor:
Tülay KUŞ, Nuriye YILDIRIM ÖZDEMİR, Gökmen AKTAŞ, Osman SÜTÇÜOĞLU, Ülkü YALÇINTAŞ ARSLAN, Merve DİRİKOÇ, Fatih KÖSE, Gülsüm AKKUŞ, Havva YEŞİL ÇINKIR, Ahmet ÖZET
Publikováno v:
Journal of Oncological Sciences. 8:127-134
Autor:
Kübra ERDOĞAN, Nisbet YILMAZ, Ahmet ERDOĞAN, Osman SÜTÇÜOĞLU, Ozan YAZICI, Nuriye YILDIRIM ÖZDEMİR
Publikováno v:
SDÜ Tıp Fakültesi Dergisi.
Objective: Colorectal cancers (CRCs) are among the most common cancers all over the world with a high mortality rate. Many prognostic factors have been identified for these cancers, one of which is the lymph node ratio (LNR). The purpose of this stud
Autor:
Nebi Serkan Demirci, Eyyup Cavdar, Nuriye Yildirim Ozdemir, Sinemis Yuksel, Yakup Iriagac, Gokmen Umut Erdem, Hatice Odabas, Ilhan Hacibekiroglu, Mustafa Karaagac, Mahmut Ucar, Banu Ozturk, Yakup Bozkaya
Publikováno v:
Medicina, Vol 60, Iss 5, p 818 (2024)
Background and Objectives: In ampullary cancer, 5-year survival rates are 30–50%, even with optimal resection and perioperative systemic therapies. We sought to determine the important clinicopathological features and adjuvant treatments in terms o
Externí odkaz:
https://doaj.org/article/8626dfe6c0064ba792f099060c6a66fb
Autor:
Mehmet Ali Nahit, Sendur, Sercan, Aksoy, Nuriye Yildirim, Özdemir, Nurullah, Zengin, Kadri, Altundağ
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 13(11)
Human epidermal growth factor receptor (HER) 2 overexpression, observed in 20-25 percent of invasive breast cancers, is well known to be associated with a more aggressive phenotype and poor prognosis, with resistance to certain chemotherapeutic agent
Autor:
Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in a
Externí odkaz:
https://doaj.org/article/1ae3c043ebb54a6c82250c0cb4ea7be9
Autor:
Tulay Kus, Fatih Kose, Gokmen Aktas, Ulku Yalcintas Arslan, Ali Murat Sedef, Havva Yesil Cinkir, Merve Dirikoc, Gulsum Akkus, Nuriye Yildirim Ozdemir
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 3, Pp 80-84 (2019)
Aim: While the main treatment of gastric cancer (GC) is surgery, controversy continues regarding appropriate lymph nodes dissection (LND) types and optimal adjuvant therapy after surgery. Therefore, we aim to analyze the survival outcomes of differen
Externí odkaz:
https://doaj.org/article/82bc304d40f34b46bd46ad3df5ee0c6d
Autor:
Yakup Bozkaya, Nuriye Yıldırım Özdemir, Gökmen Umut Erdem, Ebru Karcı Güner, Yüksel Ürün, Nebi Serkan Demirci, Ozan Yazıcı, Osman Köstek, Nurullah Zengin
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 5-10 (2018)
Objective: In this study, our aim was to identify the main predictive factors associated with pathologic complete response (pCR) to neoadjuvantchemoradiotherapy (nCRT) in patients with locally advanced rectal cancer. Methods: The patients who had loc
Externí odkaz:
https://doaj.org/article/70647a291637400dabfdedfe0c13a05f